C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Price:
34.27 CNY
1.63%
Market Closed
Updated:
May 4, 2024
CSPC Innovation Pharmaceutical Co Ltd
Operating Income
|
CSPC Innovation Pharmaceutical Co Ltd
Operating Income Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Income
¥7.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
See Also
What is CSPC Innovation Pharmaceutical Co Ltd's Operating Income?
Operating Income
787.7m
CNY
787.7m
CNY
Based on the financial report for Dec 31, 2023, CSPC Innovation Pharmaceutical Co Ltd's Operating Income amounts to 787.7m CNY.
What is CSPC Innovation Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
24%
24%
Over the last year, the Operating Income growth was 5%. The average annual Operating Income growth rates for CSPC Innovation Pharmaceutical Co Ltd have been 32% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
